APT ™ Formulation Combats Multi-Drug Resistant Candida auris: An...

Candida auris is a multi-drug resistant fungus which can be fatal. There is up to a 55% mortality rate if C. auris enters a patients’ bloodstream. Recent studies conducted at Case Western Reserve...(PRWeb February 25, 2021)Read the full story at https://www.prweb.com/releases/apt_formulation_combats_multi_drug_resistant_candida_auris_an_emerging_global_healthcare_threat/prweb17744919.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news